BRCA1, BRCA2, HER2 and RAD51 gene polymorphisms in breast cancer patients of Bangladesh

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  2015-06-11

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Updated meta-analysis on HER2 polymorphisms and risk of breast cancer: evidence from 32 studies.

  2014cited by this paper
• Relationship between Rad51 G135C and G172T Variants and the Susceptibility to Cancer: A Meta-Analysis Involving 54 Case-Control Studies

  2014cited by this paper
• Pharmacogenetic study of Fc gamma receptor and HER2 genes in breast cancer

  2013cited by this paper
• Identification of a novel BRCA2 and CHEK2 A-C-G-C haplotype in Turkish patients affected with breast cancer.

  2013cited by this paper
• HER1 R497K and HER2 I655V Polymorphisms Are Linked to Development of Breast Cancer

  2013cited by this paper
• BLM and RAD51 Genes Polymorphism and Susceptibility to Breast Cancer

  2013cited by this paper
• Polymorphisms of ERBB2 and breast cancer risk: A meta‐analysis of 26 studies involving 35,088 subjects

  2013cited by this paper
• Correlation of HER2, FCGR2A, and FCGR3A gene polymorphisms with trastuzumab related cardiac toxicity and efficacy in a subgroup of patients from UNICANCER-PACS04 trial

  2013cited by this paper
• Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India

  2013cited by this paper
• From yeast to mammals: recent advances in genetic control of homologous recombination.

  2012cited by this paper
• Mutation screening of RAD51C in high-risk breast and ovarian cancer families

  2012cited by this paper
• Single nucleotide polymorphisms of RAD51 G135C, XRCC2 Arg188His and XRCC3 Thr241Met homologous recombination repair genes and the risk of sporadic endometrial cancer in Polish women

  2012cited by this paper
• Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?

  2012cited by this paper
• Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients

  2012cited by this paper
• Screening of 185DelAG, 1014DelGT and 3889DelAG BRCA1 mutations in breast cancer patients from North-East India.

  2012cited by this paper
• A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer

  2012cited by this paper
• Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families.

  2012cited by this paper
• Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC).

  2012cited by this paper
• HER2 Ile655Val and PTEN IVS4 polymorphisms in patients with breast cancer

  2012cited by this paper
• Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families

  2012cited by this paper
• RAD51 polymorphisms and breast cancer risk

  2012cited by this paper
• RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies

  2011cited by this paper
• Determining true HER2 gene status in breast cancers with polysomy by using alternative chromosome 17 reference genes: implications for anti-HER2 targeted therapy.

  2011cited by this paper
• RAD51C is a susceptibility gene for ovarian cancer.

  2011cited by this paper
• Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.

  2011cited by this paper
• Implications of rarity of chromosome 17 polysomy in breast cancer.

  2011cited by this paper
• Lack of replication for the association between HER2 I655V polymorphism and breast cancer risk: a systematic review and meta-analysis.

  2011cited by this paper
• Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or younger

  2011cited by this paper
• Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.

  2011cited by this paper
• Single nucleotide polymorphisms in the homologous recombination repair genes and breast cancer risk in Polish women.

  2011cited by this paper
• BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer

  2011cited by this paper
• Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility

  2011cited by this paper
• A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families

  2011cited by this paper
• HER2 genetic heterogeneity in breast carcinoma

  2011cited by this paper
• Screening of women at high risk for breast cancer.

  2011cited by this paper
• RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumorigenesis.

  2011cited by this paper
• RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies

  2011cited by this paper
• A functional polymorphism of TGFBR2 is associated with risk of breast cancer with ER(+), PR(+), ER(+)PR(+) and HER2(-) expression in women.

  2011cited by this paper
• Need for clarification of data in the recent meta-analysis about RAD51 135G>C polymorphism and breast cancer risk

  2011cited by this paper
• RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families

  2011cited by this paper
• HER2 codon 655 polymorphism is associated with advanced uterine cervical carcinoma.

  2010cited by this paper
• RAD51 G135C polymorphism is associated with breast cancer susceptibility: a meta-analysis involving 22,399 subjects

  2010cited by this paper
• ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer

  2010cited by this paper
• Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

  2010cited by this paper
• RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects

  2010cited by this paper
• Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population.

  2010cited by this paper
• Profile of breast cancer patients at a tertiary care hospital in north India.

  2010cited by this paper
• RAD51C germline mutations in breast and ovarian cancer patients

  2010cited by this paper
• DNA damage and repair in endometrial cancer in correlation with the hOGG1 and RAD51 genes polymorphism

  2010cited by this paper
• HER2 Polymorphisms and Breast Cancer in Tunisian Women

  2010cited by this paper
• Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility: meta-analysis of 22 studies involving 19,341 subjects

  2010cited by this paper
• P53 Codon 72 and HER2 Codon 655 Polymorphisms in Turkish Breast Cancer Patients

  2010cited by this paper
• A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)

  2009cited by this paper
• Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases.

  2009cited by this paper
• Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers?

  2009cited by this paper
• Association between polymorphisms of the BRCA2 gene and clinical parameters in breast cancer.

  2009cited by this paper
• Missense Polymorphisms in BRCA1 and BRCA2 and Risk of Breast and Ovarian Cancer

  2009cited by this paper
• HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis

  2009cited by this paper
• Molecular mechanism of protein assembly on DNA double-strand breaks in the non-homologous end-joining pathway.

  2009cited by this paper
• Breast cancer. Clinical practice guidelines in oncology.

  2009cited by this paper
• Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma

  2009cited by this paper
• Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer.

  2009cited by this paper
• BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation

  2009cited by this paper
• A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy.

  2008cited by this paper
• The Influence of HER2 Genotypes as Molecular Markers on Breast Cancer Outcome

  2008cited by this paper
• ErbB antagonists patenting: "playing chess with cancer".

  2008cited by this paper
• Cell Cycle-dependent Complex Formation of BRCA1·CtIP·MRN Is Important for DNA Double-strand Break Repair*

  2008cited by this paper
• Assessment of Suspected Cancer

  2008cited by this paper
• Polymorphisms in RAD51, XRCC2, and XRCC3 Are Not Related to Breast Cancer Risk

  2008cited by this paper
• Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.

  2008cited by this paper
• DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population

  2007cited by this paper
• RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites

  2007cited by this paper
• Genetic susceptibility for breast cancer: how many more genes to be found?

  2007cited by this paper
• Genetic analysis of the BRCA1 and BRCA2 genes in breast cancer of HongKong Chinese

  2007cited by this paper
• Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations

  2007cited by this paper
• Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients.

  2007cited by this paper
• American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

  2007cited by this paper
• The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis

  2007cited by this paper
• 655Val and 1170Pro ERBB2 SNPs in Familial Breast Cancer Risk and BRCA1 Alterations

  2007cited by this paper
• Interactions between human BRCA2 protein and the meiosis‐specific recombinase DMC1

  2007cited by this paper
• Cancer risks among BRCA1 and BRCA2 mutation carriers

  2007cited by this paper
• Ubiquitin-Binding Protein RAP80 Mediates BRCA1-Dependent DNA Damage Response

  2007cited by this paper
• Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India

  2006cited by this paper
• Investigation of HER-2 codon 655 single nucleotide polymorphism frequency and c-ErbB-2 protein expression alterations in gastric cancer patients.

  2006cited by this paper
• HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry

  2006cited by this paper
• Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.

  2006cited by this paper
• The role of double-strand break repair — insights from human genetics

  2006cited by this paper
• Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study

  2006cited by this paper
• Characterization of BRCA1 and BRCA2 mutations in a large United States sample.

  2006cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

  2006cited by this paper
• Significance, detection and markers of disseminated breast cancer cells.

  2006cited by this paper
• Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis.

  2006cited by this paper
• The role of BRCA1 in non-homologous end-joining.

  2006cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients

  2006cited by this paper
• Alcohol and endogenous sex steroid levels in postmenopausal women: a cross-sectional study.

  2005cited by this paper
• An Amino-terminal Motif Functions as a Second Nuclear Export Sequence in BRCA1*

  2005cited by this paper
• Prevalence of BRCA Mutations and Founder Effect in High-Risk Hispanic Families

  2005cited by this paper
• DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil.

  2005cited by this paper
• Characterisation of the promoter region of the human DNA-repair gene Rad51.

  2005cited by this paper
• Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome.

  2005cited by this paper

• Molecular study of BRCA-1,2 and P53 gene polymorphisms among post-operative breast cancer patients

  2019influential citation